{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T01:32:25Z","timestamp":1714527145423},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,16]]},"DOI":"10.7759\/cureus.30346","type":"journal-article","created":{"date-parts":[[2022,10,16]],"date-time":"2022-10-16T10:19:35Z","timestamp":1665915575000},"source":"Crossref","is-referenced-by-count":1,"title":["Acute Kidney Injury Caused by Renin-Angiotensin System Inhibitors During Minimal Change Disease Treatment"],"prefix":"10.7759","author":[{"given":"Kenta","family":"Torigoe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Ikemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayuko","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Muta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.04.024","article-title":"Acute kidney injury complicating nephrotic syndrome of minimal change disease","volume":"94","author":"Meyrier A","year":"2018","unstructured":"Meyrier A, Niaudet P. Acute kidney injury complicating nephrotic syndrome of minimal change disease. Kidney Int. 2018, 94:861-869. 10.1016\/j.kint.2018.04.024","journal-title":"Kidney Int"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-020-01992-8","article-title":"Clinical and histopathological features of acute kidney injury in adult-onset minimal change nephrotic syndrome","volume":"25","author":"Nishide K","year":"2021","unstructured":"Nishide K, Nakatani S, Mori K, et al.. Clinical and histopathological features of acute kidney injury in adult-onset minimal change nephrotic syndrome. Clin Exp Nephrol. 2021, 25:261-269. 10.1007\/s10157-020-01992-8","journal-title":"Clin Exp Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55070365","article-title":"Pathogenesis and management of acute kidney injury in patients with nephrotic syndrome due to primary glomerulopathies","volume":"55","author":"Lionaki S","year":"2019","unstructured":"Lionaki S, Liapis G, Boletis JN. Pathogenesis and management of acute kidney injury in patients with nephrotic syndrome due to primary glomerulopathies. Medicina (Kaunas). 2019, 55:365. 10.3390\/medicina55070365","journal-title":"Medicina (Kaunas)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-015-1216-x","article-title":"Evidence-based clinical practice guidelines for nephrotic syndrome 2014","volume":"20","author":"Nishi S","year":"2016","unstructured":"Nishi S, Ubara Y, Utsunomiya Y, et al.. Evidence-based clinical practice guidelines for nephrotic syndrome 2014. Clin Exp Nephrol. 2016, 20:342-370. 10.1007\/s10157-015-1216-x","journal-title":"Clin Exp Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","unstructured":"Kidney Disease. Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group: KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021, 100:S1-S276. 10.1016\/j.kint.2021.05.021","journal-title":"Kidney Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012690","article-title":"Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study","volume":"6","author":"Mansfield KE","year":"2016","unstructured":"Mansfield KE, Nitsch D, Smeeth L, Bhaskaran K, Tomlinson LA. Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study. BMJ Open. 2016, 6:e012690. 10.1136\/bmjopen-2016-012690","journal-title":"BMJ Open"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03531006","article-title":"Adult minimal-change disease: clinical characteristics, treatment, and outcomes","volume":"2","author":"Waldman M","year":"2007","unstructured":"Waldman M, Crew RJ, Valeri A, et al.. Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol. 2007, 2:445-453. 10.2215\/CJN.03531006","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/20009666.2019.1688125","article-title":"Adult minimal change disease with acute kidney injury: a case report and literature review","volume":"9","author":"Nicholas PD 3rd","year":"2019","unstructured":"Nicholas PD 3rd, Garrahy I. Adult minimal change disease with acute kidney injury: a case report and literature review. J Community Hosp Intern Med Perspect. 2019, 9:507-510. 10.1080\/20009666.2019.1688125","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0272-6386(13)80001-7","article-title":"Reversible renal failure in the nephrotic syndrome","volume":"19","author":"Smith JD","year":"1992","unstructured":"Smith JD, Hayslett JP. Reversible renal failure in the nephrotic syndrome. Am J Kidney Dis. 1992, 19:201-213. 10.1016\/s0272-6386(13)80001-7","journal-title":"Am J Kidney Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1986.130","article-title":"Adult-onset minimal change nephrotic syndrome: a long-term follow-up","volume":"29","author":"Nolasco F","year":"1986","unstructured":"Nolasco F, Cameron JS, Heywood EF, Hicks J, Ogg C, Williams DG. Adult-onset minimal change nephrotic syndrome: a long-term follow-up. Kidney Int. 1986, 29:1215-1223. 10.1038\/ki.1986.130","journal-title":"Kidney Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00683.x,","article-title":"Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure","volume":"62","author":"Carvounis CP","year":"2002","unstructured":"Carvounis CP, Nisar S, Guro-Razuman S. Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int. 2002, 62:2223-2229. 10.1046\/j.1523-1755.2002.00683.x,","journal-title":"Kidney Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2021.06.003","article-title":"Point-of-care ultrasound in acute care nephrology","volume":"28","author":"Karakala N","year":"2021","unstructured":"Karakala N, C\u00f3rdoba D, Chandrashekar K, Lopez-Ruiz A, Juncos LA. Point-of-care ultrasound in acute care nephrology. Adv Chronic Kidney Dis. 2021, 28:83-90. 10.1053\/j.ackd.2021.06.003","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf S","year":"2008","unstructured":"Yusuf S, Teo KK, Pogue J, et al.. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008, 358:1547-1559. 10.1056\/NEJMoa0801317","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-022-02720-y","article-title":"Acute kidney injury in patients with primary nephrotic syndrome: influencing factors and coping strategies","volume":"23","author":"Lu H","year":"2022","unstructured":"Lu H, Xiao L, Song M, Liu X, Wang F. Acute kidney injury in patients with primary nephrotic syndrome: influencing factors and coping strategies. BMC Nephrol. 2022, 23:90. 10.1186\/s12882-022-02720-y","journal-title":"BMC Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.06620615","article-title":"AKI in children hospitalized with nephrotic syndrome","volume":"10","author":"Rheault MN","year":"2015","unstructured":"Rheault MN, Zhang L, Selewski DT, et al.. AKI in children hospitalized with nephrotic syndrome. Clin J Am Soc Nephrol. 2015, 10:2110-2118. 10.2215\/CJN.06620615","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref16","article-title":"Reversible renal failure in hypertensive idiopathic nephrotics treated with captopril","volume":"17","author":"Olowu WA","year":"2006","unstructured":"Olowu WA, Adenowo OA, Elusiyan JB. Reversible renal failure in hypertensive idiopathic nephrotics treated with captopril. Saudi J Kidney Dis Transpl. 2006, 17:216-221.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1159\/000507426","article-title":"Acute kidney injury associated with minimal change nephrotic syndrome in an elderly patient successfully treated with both fluid management and specific therapy based on kidney biopsy findings","volume":"10","author":"Oyama Y","year":"2020","unstructured":"Oyama Y, Iwafuchi Y, Morioka T, Narita I. Acute kidney injury associated with minimal change nephrotic syndrome in an elderly patient successfully treated with both fluid management and specific therapy based on kidney biopsy findings. Case Rep Nephrol Dial. 2020, 10:42-50. 10.1159\/000507426","journal-title":"Case Rep Nephrol Dial"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/119558-acute-kidney-injury-caused-by-renin-angiotensin-system-inhibitors-during-minimal-change-disease-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:55Z","timestamp":1707507715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/119558-acute-kidney-injury-caused-by-renin-angiotensin-system-inhibitors-during-minimal-change-disease-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,16]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.30346","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,16]]}}}